Oric Pharmaceuticals (ORIC) Payables (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Payables came in at $2.9 million in Q1 2026, down 43.9% YoY from $5.2 million in Q1 2025, and down 24.29% on a QoQ basis from $3.8 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Payables (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Payables data on file, last reported at $2.9 million in Q1 2026.
- Quarterly Payables fell 43.9% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 43.9% YoY) and the FY2025 annual result came in at $3.8 million, up 147.03% from the prior year.
- Payables eased to $2.9 million in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Payables ranged from a high of $5.2 million in Q1 2025 to a low of $888000.0 in Q1 2022.
- A 5-year average of $2.6 million and a median of $2.9 million in 2026 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables jumped 265.63% — and 2026, when it plunged 43.9%.
- Tracing ORIC's Payables over 5 years: stood at $1.3 million in 2022, then retreated by 28.48% to $944000.0 in 2023, then surged by 63.98% to $1.5 million in 2024, then jumped by 147.03% to $3.8 million in 2025, then declined by 24.29% to $2.9 million in 2026.
- The last three Payables figures came in at $2.9 million (Q1 2026), $3.8 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | 3.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.87 Mn |
| Mar 31, 2026 | 2.90 Mn |
| Dec 31, 2025 | 3.82 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 3.13 Mn |
| Mar 31, 2025 | 5.16 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | 944,000.00 |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 3.19 Mn |
| Mar 31, 2023 | 1.93 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 888,000.00 |
| Dec 31, 2021 | 1.89 Mn |
| Sep 30, 2021 | 419,000.00 |